Purpose The purpose of this study is to examine knowledge and perceptions of risk
surrounding chronic inflammatory diseases (CIDs) and intergenerational development, as …

Background Many patients with inflammatory bowel disease (IBD) may use cannabis for
relief of symptoms. During pregnancy, however, cannabis exposure may be associated with …

The last two decades have seen an increase in the incidence of inflammatory bowel disease
(IBD) in many regions of the world, which has had a significant impact on both the social and …

Background Mobile health applications (apps) providing diet and lifestyle self-management
programs to patients with inflammatory bowel disease (IBD) are emerging. The objective of …

Background The symptom burden in inflammatory bowel disease (IBD) has a significant
negative impact on the health-related quality of life (HRQOL). Patients with IBD report …

Canada has one of the highest rates of inflammatory bowel disease (IBD) in the world, with 1
in 140 Canadians currently living with the disease. IBD occurs less often among individuals …

Inflammatory bowel disease (IBD), a chronic, recurring inflammatory response, is a growing
global public health issue. It results from the aberrant crosstalk among environmental …

Abstract Crohn's disease (CD), together with ulcerative colitis (CD) and inflammatory bowel
disease-unclassified (IBD-U), belongs to the group of inflammatory bowel diseases (IBDs) …

Literature exploring the health-related quality of life and care experiences of older adults
with inflammatory bowel disease is limited despite the increasing prevalence in this …

Abstract Background and Aims Corticosteroid-free remission is a primary treatment goal in
IBD which may be achieved with greater use of anti-TNF therapy. We defined temporal …